Brain Development
9
3
5
2
Key Insights
Highlights
Success Rate
67% trial completion
Clinical Risk Assessment
Based on trial outcomes
Moderate Risk
Score: 47/100
11.1%
1 terminated out of 9 trials
66.7%
-19.9% vs benchmark
0%
0 trials in Phase 3/4
100%
2 of 2 completed with results
Key Signals
Data Visualizations
Phase Distribution
Trial Status
Trial Success Rate
Benchmark: 86.5%
Based on 2 completed trials
Clinical Trials (9)
Pilot Study of Prenatal Choline Supplementation
Baby's First Years
Clinical Applications of High-Frequency Oscillations
Evaluating a Strengths-based Community-grounded Intervention
Creation of a Database of Healthy Subjects With 18FDG PET Brain Imaging as Part of the MOBILE Project (Multimodal Whole-Brain Imaging in Epilepsy)
The Brain Mechanism of Social Emotion and Communication in Infants Aged 0 to 6 Years
Brain Health and Development With T1DM
Randomized Trial of Maternal Progesterone Therapy
Effect of Fish Oil on Athlete's Executive Function